Pallas Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 13,369 shares of APLS stock, worth $406,283. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,369
Previous 13,923
3.98%
Holding current value
$406,283
Previous $401,000
6.23%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
310Shares Held
113MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$473 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$361 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$338 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$176 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.34B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...